slow start today after yesterday's spike and volume on launch ... good to see a spec buy still in the market ... consolidated in the high .70s and .80s before the next few announcements on distribution roll out ... company is looking to become profitable and certainly doesn't want to be taken out too early. any cut through in product here and the likes of resmed will be calling imv
there's still some growth in this up to $1 imv, but may take a little while now for the instos to arrive and start supporting these new levels.
thought?
Add to My Watchlist
What is My Watchlist?